$COO

The Cooper Companies (COO) lowered its fiscal 2026 profit and revenue forecasts due to weaker-than-expected contact lens demand, with adjusted EPS now expected at $4.51–$4.55 and revenue at $4.23–$4.25 billion. Q3 revenue was $1.07 billion, missing estimates, though adjusted EPS beat at $1.15. The company cited U.S. channel inventory reductions as a key factor and decided to retain CooperSurgical.

U.S. markets ended lower amid rising Treasury yields and inflation data. Apple unveiled its $1,999 foldable iPhone Duo. Novartis shares fell 14% after a drug trial failure. Meta introduced its AI agent, Muse. Oracle shares jumped on strong earnings. Quantum computing stocks rallied on CHIPS Act funding. Adobe shares fell despite beating estimates. Skyworks Solutions rose 19% over the week. CooperCompanies fell on lowered guidance. Macy's reported stronger-than-expected Q2 results.

Cooper Companies (COO) fell 14.67% after reporting Q3 revenue of $1.07B and Q4 guidance below estimates. Freeport-McMoRan (FCX) dropped 6.59% due to White House uncertainty on copper tariffs. Baker Hughes (BKR) declined 6.66% despite raising its full-year revenue guidance to $28.5B-$30.3B.

CooperCompanies reported Q2 revenue of $1.07B (flat YoY, 2.9% miss) and adjusted EPS of $1.15 (2.7% beat). Full-year guidance was lowered to $4.24B revenue and $4.53 EPS. The company reduced U.S. inventory and retained CooperSurgical after a strategic review. Management plans to invest in sales and R&D, aiming for future growth and improved margins.

The Cooper Companies (COO) completed its strategic review, deciding not to sell CooperSurgical. The board cited temporary valuation impacts, including competition and litigation, for the decision. The company plans to focus on capital allocation, organic growth, and fertility sector expansion.

Cooper Companies (COO) reported Q3 earnings that beat EPS estimates but missed on revenue, leading to a 14.07% drop in share price. Revenue was $1.066B vs. $1.10B estimate, and adjusted EPS was $1.15 vs. $1.12 estimate. Management attributed the revenue miss to inventory destocking and expects recovery in Q4. The company also abandoned the sale of CooperSurgical due to valuation concerns. Next catalysts include Q4 earnings, inventory normalization, and FY2027 guidance.

US stock futures declined for the third day, with tech underperforming as Treasury yields rose. S&P futures fell 0.2%, Nasdaq futures dropped 0.5%. TSMC reported a 53% sales increase. Oracle earnings and US PPI data are upcoming. Key movers: AAPL, META up 1.0%; TSLA, NVDA down. AVAV +4%, AEO -14%, COO -16%, JBLU -2%, KNTK +4%, M -1%, NAVN -15%, RXT +13%. Oil prices rose, ECB rate decision awaited. Trump's $5k dividend proposal met with skepticism.

JPMorgan upgraded Meta (META) to Overweight with a $820 target, citing AI-driven growth. Wells Fargo upgraded Synopsys (SNPS) to Overweight with a $475 target, and Yum! Brands (YUM) to Overweight with a $175 target. StoneX upgraded Block (XYZ) to Buy with a $105 target. Freedom Broker upgraded Caterpillar (CAT) to Buy with a $980 target. Arete downgraded Uber (UBER) to Neutral with a $74 target. Evercore ISI downgraded Chewy (CHWY) to In Line with a $25 target. William Blair downgraded Cooper Co

Macy's (M) reported Q2 revenue beat, raised guidance, shares down 1.6%. Meta (META) rose 1.4% on JPMorgan upgrade. Apple (AAPL) up 1% post-foldable iPhone launch. Novartis (NVS) gained 2% after shareholder called for board overhaul. Copper miners Freeport-McMoRan (FCX) and Southern Copper (SCCO) fell ~7% and 6% respectively. AeroVironment (AVAV) jumped 5% on Q1 earnings beat. American Eagle (AEO) dropped 15% after Q2 sales miss. Navan (NAV) sank 15.4% despite slight earnings beat. Cooper Compani

JPMorgan upgraded Meta (META) to Overweight with an $820 target. Piper Sandler initiated AMD and NVIDIA (NVDA) with Overweight ratings. Gold hit $4,400, Bitcoin rose to $78,000. Brent Crude surpassed $100. Markets fell due to rising rates and geopolitical tensions. August inflation data is expected to impact Fed rate hike decisions.